BAX

Spectral Medical Announces Third Quarter Results and Provides Corporate Update

Retrieved on: 
Thursday, November 9, 2023
BAX, NYSE, Clinical professor, Septic shock, Emory Healthcare, Mortality, FX, Sepsis, Grace note, Balancing, USD, Patient, TSX, Mayo Clinic, Pharmaceutical industry, Nursing, Fine chemical, Baxter, Spectral

TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the third quarter ended September 30, 2023 and provided a corporate update.

Key Points: 
  • TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the third quarter ended September 30, 2023 and provided a corporate update.
  • During the third quarter, the Company continued to experience momentum in Tigris Trial enrollment.
  • Dr. John Kellum, Chief Medical Officer of Spectral Medical, stated, “We continue to experience patient enrollment momentum supported by new sites we have onboarded during 2023.
  • The Company concluded the third quarter of 2023 with cash of $5,031,000 compared to $8,414,000 of cash on hand as of December 31, 2022.

Lifshitz Law PLLC Announces Investigations of ImmunityBio, Inc. (NASDAQ: IBRX), BioXcel Therapeutics, Inc. (NASDAQ: BTAI), Baxter International Inc. (NYSE: BAX)

Retrieved on: 
Sunday, October 1, 2023
GMP, Institutional review board, Face, Telephone, CMOS, Record, Dementia, Patient, Advertising, BAX, FDA, ImmunityBio COVID-19 vaccine, Agitation, Hewlett, Safety, Online shopping

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) --

Key Points: 
  • If you are an IBRX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a BTAI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780.
  • Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Baxter International Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 11, 2023 – (NYSE: BAX)

Retrieved on: 
Friday, September 8, 2023
Baxter International, NEXT, Fraud, Face, BAX, Holding company, Security (finance)

Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.

Key Points: 
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • DEADLINE: September 11, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is September 11, 2023.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 11, 2023 in the Class Action Filed on Behalf of Baxter International Inc. (BAX) Shareholders

Retrieved on: 
Wednesday, September 6, 2023
Telephone, COST, Baxter, CLASS, Baxter International, HOW, NYSE, Face, BAX

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.

Key Points: 
  • NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Baxter you have until September 11, 2023 to petition the court for lead plaintiff status.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Lifshitz Law PLLC Announces Investigations of Arrow Financial Corp. (NASDAQ: AROW), ImmunityBio, Inc. (NASDAQ: IBRX), BioXcel Therapeutics, Inc. (NASDAQ: BTAI), and Baxter International Inc. (NYSE: BAX)

Retrieved on: 
Sunday, September 3, 2023
GMP, Institutional review board, Face, Telephone, Disclosure, CMOS, Arrow, Record, Dementia, Patient, Advertising, Risk, BAX, FDA, ImmunityBio COVID-19 vaccine, Agitation, Hewlett, Safety, Pharmaceutical industry, Online shopping

If you are an AROW investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.

Key Points: 
  • If you are an AROW investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are an IBRX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.
  • Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 11, 2023 in the Class Action Filed on Behalf of Baxter International Inc.(BAX) Shareholders

Retrieved on: 
Thursday, August 31, 2023
Telephone, COST, Baxter, CLASS, Baxter International, HOW, NYSE, Face, BAX

NEW YORK, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.

Key Points: 
  • NEW YORK, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Baxter you have until September 11, 2023 to petition the court for lead plaintiff status.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Baxter International Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 11, 2023 – (NYSE: BAX)

Retrieved on: 
Wednesday, August 30, 2023
Baxter International, NEXT, Fraud, Face, BAX, Holding company, Security (finance)

Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.

Key Points: 
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • DEADLINE: September 11, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is September 11, 2023.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Baxter International Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 11, 2023 – (NYSE: BAX)

Retrieved on: 
Friday, August 25, 2023
Baxter International, NEXT, Fraud, Face, BAX, Holding company, Security (finance)

Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.

Key Points: 
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • DEADLINE: September 11, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is September 11, 2023.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

BAX Investors Should Contact Robbins LLP About Participating in the Class Action Against Baxter International, Inc.

Retrieved on: 
Wednesday, August 23, 2023
Baxter International, Complaint, Baxter, LLP, Motion, Supply, Impact, NYSE, SAN, BAX, Kidney disease, Person, Security (finance), Inc.

SAN DIEGO, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Baxter International, Inc. (NYSE: BAX) securities between May 25, 2022 and February 8, 2023.

Key Points: 
  • SAN DIEGO, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Baxter International, Inc. (NYSE: BAX) securities between May 25, 2022 and February 8, 2023.
  • Baxter is a multi-national healthcare company, primarily focusing on products designed to treat kidney disease and other chronic and acute medical conditions.
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • Defendants’ failure to disclose Baxter’s true problems relating to its supply chain deceived investors about the Company’s true financial health and earnings.

BAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 11, 2023 in the Class Action Filed on Behalf of Baxter International Inc. Shareholders

Retrieved on: 
Tuesday, August 22, 2023
Telephone, COST, Baxter, CLASS, Baxter International, HOW, NYSE, Face, BAX

NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.

Key Points: 
  • NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
  • HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the BAX lawsuit, please contact J. Klein, Esq.